Derakhshan Behrad
SEC insider (Form 3/4/5 filer). CIK 0001853109. Chief Business Officer at Edgewise Therapeutics, Inc. (EWTX). 19 reported Form 4/5 transactions since Sep 2024; latest on Aug 12, 2026. Located in BOULDER, CO.
Companies Derakhshan Behrad has filed insider reports for
- Edgewise Therapeutics, Inc. (EWTX): Officer, Chief Business Officer
Derakhshan Behrad
CIK: 0001853109
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Edgewise Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
100K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect304 shares at avg. $44.50$14K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect5.8K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
ExerciseDirect7.5K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect2.2K shares at avg. $43.79$95K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect150 shares at avg. $44.44$7K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
SaleDirect2.5K shares at avg. $43.70$108K - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectRestricted Stock Units
50K shares- - Aug 12, 2026EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
100K shares- - Aug 12, 2025EWTX
Edgewise Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
180K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 304 | $44.50 | $13,529 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 5,781 | - | $0 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Exercise | 7,500 | - | $0 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 2,171 | $43.79 | $95,075 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 150 | $44.44 | $6,666 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Sale | 2,475 | $43.70 | $108,154 | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Restricted Stock Units | 50,000 | - | - | Direct |
| Aug 12, 2026 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 100,000 | - | - | Direct |
| Aug 12, 2025 | EWTX Edgewise Therapeutics, Inc. | Award Stock Option (Right to Buy) | 180,000 | - | - | Direct |
1-10 of 19 transactions